Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GC40022 Roridin E A trichothecene mycotoxin
  3. GC40009 Bostrycin

    Rhodosporin

    An anthraquinone with diverse biological activities
  4. GC40007 Malformin A

    Malformin A1

    A cyclopentapeptide fungal metabolite with diverse biological activities
  5. GC34389 PUMA BH3 PUMABH3是一种p53正向凋亡调控因子(PUMA)BH3结构域多肽,作为Bak的直接激活剂,Kd值为26nM。
  6. GC34303 Taltobulin hydrochloride (HTI-286 hydrochloride) An inhibitor of microtubule polymerization
  7. GC34263 Bak BH3 BakBH3是一种多肽,源于Bak蛋白的BH3结构域,在细胞中,能够抑制Bcl-xL的活性。
  8. GC34218 Nivolumab (BMS-936558)

    纳武单抗; BMS-936558; ONO-4538; MDX-1106

    Nivolumab 是一种抗癌单克隆抗体,是一种程序性死亡受体-1 阻断人 IgG4 抗体,用于治疗晚期(转移性)非小细胞肺癌。
  9. GC34214 Adalimumab (Anti-Human TNF-alpha, Human Antibody)

    阿达木单抗; Anti-Human TNF-alpha, Human Antibody

    阿达木单抗(抗人 TNF-α,人抗体)是治疗类风湿性关节炎的主要疗法之一。

  10. GC34181 Tauroursodeoxycholate (TUDCA)

    牛磺熊去氧胆酸; Tauroursodeoxycholic acid; TUDCA; UR 906

    牛磺酸脱氧胆酸盐(TUDCA)是包括肝细胞在内的多种细胞的细胞保护剂,也是癌症细胞凋亡的诱导剂。
  11. GC34177 Sesamol

    芝麻酚

    A lignan with diverse biological activities
  12. GC34172 AP1867 AP1867是合成的FKBP12F36V的配体。
  13. GC34157 Desacetylcinobufotalin (Deacetylcinobufotalin)

    去乙酰华蟾蜍它灵,Deacetylcinobufotalin

    Desacetylcinbufotalin (Deacetylcinbufotalin) 是一种天然化合物;凋亡诱导剂,对HepG2细胞有明显抑制作用,IC50值为0.0279μ;mol/ml。
  14. GC34134 Glycocholic acid

    甘氨胆酸

    Glycocholic acid是一种参与脂肪乳化的结晶胆汁酸,是胆酸与甘氨酸的结合物,它以钠盐的形式存在于哺乳动物的胆汁中。
  15. GC34125 (E)-[6]-Dehydroparadol (E)-[6]-Dehydroparadol来自专利US9272994化合物M15,能够抑制人体癌细胞生长并且诱导细胞凋亡。在HCT-116和H-1299细胞中的IC50值分别为43.02和41.59μM。
  16. GC34096 (R)-(-)-Gossypol acetic acid (AT-101 (acetic acid))

    (R)-(-)-醋酸棉酚; AT-101 (acetic acid); (-)-Gossypol acetic acid; (R)-Gossypol acetic acid

    (R)-(-)-Gossypol acetic acid (AT-101 (acetic acid))是一种新型的、具有口服活性的Bcl-2家族蛋白抑制剂,可抑制Bcl-2(Ki=260±30nM),Mcl-1(Ki=170±10nM)和Bcl-xL(Ki=480±40nM)。
  17. GC34095 ONC212 ONC212是ONC201的化学类似物,是一种氟化咪唑啉酮。
  18. GC34093 SAFit2 SAFit2是一种强效的FK506-binding protein 51 (FKBP51)抑制剂,Ki值为6nM。
  19. GC34092 Glycochenodeoxycholic acid (Chenodeoxycholylglycine)

    甘氨鹅脱氧胆酸; Chenodeoxycholylglycine

    A quantitative analytical standard guaranteed to meet MaxSpec? identity, purity, stability, and concentration specifications
  20. GC34070 Brusatol

    鸦胆子苦醇; NSC 172924

    Brusatol是一种Nrf2抑制剂,由从鸦嘴茅中分离提取。
  21. GC34057 TBHQ (tert-Butylhydroquinone)

    特丁基对苯二酚; tert-Butylhydroquinone

    TBHQ(tert-Butylhydroquinone)是一种强效的酚类抗氧化剂,能够减轻氧化应激和炎症反应。
  22. GC34021 Vitamin K4 (acetomenaphthone)

    维生素K4; acetomenaphthone

    A synthetic form of vitamin K
  23. GC34010 Danshensu (Dan shen suan A)

    丹参素; Dan shen suan A; Salvianic acid A

    丹参素是丹参的一种活性成分,通过激活 Nrf2 信号通路显示出广泛的心血管益处。
  24. GC33934 DCVC

    S-[(1E)-1,2-dichloroethenyl]--L-cysteine

    DCVC (S-[(1E)-1,2-dichloroethenyl]--L-cysteine) 是三氯乙烯 (TCE) 的生物活性代谢物。
  25. GC33831 Lidocaine hydrochloride (Lignocaine hydrochloride)

    盐酸利多卡因; Lignocaine hydrochloride

    Lidocaine hydrochloride (Lignocaine hydrochloride)是一种氨基酰胺类局部麻醉剂,可抑制voltage-insensitive ‘flicker’ K+ channel,IC50值为220μM。
  26. GC33826 C 87 C87是一种新型小分子TNFα抑制剂;高效抑制TNFα诱导的细胞毒性,IC50值为8.73μM。
  27. GC33825 Taurochenodeoxycholic acid (12-Deoxycholyltaurine)

    牛磺鹅去氧胆酸; 12-Deoxycholyltaurine

    Taurochenodeoxycholic acid (12-Deoxycholyltaurine)是一种牛磺酸结合胆汁酸。
  28. GC33815 4-Hydroxyphenylacetic acid

    4-羟基苯乙酸

    A phenolic acid with anti-inflammatory and anti-steatotic activities
  29. GC33779 Cysteamine (β-Mercaptoethylamine)

    巯基乙胺

    2-Aminoethanethiol (cysteamine, β-Mercaptoethylamine, 2-Mercaptoethylamine, Thioethanolamine, Mercaptamine) is a radiation-protective agent that oxidizes in air to form cystamine.
  30. GC33699 SAFit1 SAFit1 是一种 FK506 结合蛋白 51(FKBP51)特异性抑制剂,其 Ki 值为 4 ± 0.3nM。
  31. GC33620 Nec-4 Nec-4,一个三环衍生物,是受体相互作用蛋白1(RIP1)的一个有效抑制剂,其IC50值为2.6μM,Ki值为0.46μM。
  32. GC33501 Bornyl acetate

    (-)-乙酸龙脑酯; L-(-)-Bornyl acetate

    An acetate form of borneol
  33. GC19485 DC661 DC661是一种能够抑制棕榈酰蛋白硫酯酶1(PPT1)并有效抑制细胞自噬的小分子化合物,可作为抗溶酶体剂。
  34. GC33407 BM 957 BM957是Bcl-2和Bcl-xL的有效抑制剂,其Ki值分别为1.2,<1nM,IC50值分别为5.4,6.0nM。
  35. GC33401 S55746 hydrochloride (BLC201 (hydrochloride))

    BCL201 hydrochloride

    S55746 hydrochloride (BLC201 (hydrochloride)) (BCL201 hydrochloride) 是一种有效的,具有口服活性的选择性 BCL-2 抑制剂,Ki 为 1.3 nM,Kd 为 3.9 nM。 S55746 hydrochloride (BLC201 (hydrochloride)) (BCL201 hydrochloride) 具有低毒的抗肿瘤活性。
  36. GC33384 DPBQ DPBQ是一种p53激活剂。
  37. GC33364 Mcl1-IN-4 Mcl1-IN-4是Mcl1的抑制剂,IC50值为0.2μM。
  38. GC33356 AM-8735 AM-8735是有效,选择性的MDM2抑制剂,IC50值为25nM。
  39. GC33347 Mcl1-IN-3 Mcl1-IN-3是Mcl1的抑制剂,来自专利专利WO2015153959A2,化合物实例57;IC50和Ki值分别为0.67和0.13μM。
  40. GC33337 CDC801

    CDC801是一种强效的磷酸二酯酶4(PDE4)和肿瘤坏死因子-α(TNF-α)抑制剂。IC50分别为1.1μM和2.5μM。

  41. GC33330 Cynaropicrin

    菜蓟苦素

    A sesquiterpene lactone
  42. GC33312 ML311 An Mcl-1 inhibitor
  43. GC33309 ML132 (NCGC 00185682)

    NCGC-00183434

    ML132 (NCGC 00185682) (NCGC-00183434) 是一种选择性 caspase 1 抑制剂,IC50 为 34.9 nM。

  44. GC33295 MIK665 (S-64315)

    S-64315

    An Mcl-1 inhibitor
  45. GC33291 Tubulin inhibitor 1 Tubulininhibitor1是tubulin抑制剂,靶作用于秋水仙素结合位点,抑制微管蛋白聚集。Tubulininhibitor1具有抗肿瘤活性,能够导致细胞G2/M期有丝分裂停滞,诱导细胞凋亡。
  46. GC33283 AZD-5991 Racemate AZD5991 is a macrocyclic MCL-1 inhibitor with sub-nanomolar affinity for MCL-1 (Ki = 0.13 nM). The binding affinity of AZD5991 is about 25-fold lower for mouse Mcl-1 vs. human Mcl-1 but only four-fold lower for rat Mcl-1.
  47. GC33255 AZD4320 AZD4320是BH-3的新型类似物,有效的BCL2/BCLxL的双重抑制剂。AZD4320对于KPUM-MS3,KPUM-UH1,和STR-428细胞系的IC50分别为26nM,17nM,和170nM。
  48. GC33247 AZD-5991 An Mcl-1 inhibitor
  49. GC33239 AZD-5991 S-enantiomer AZD-5991S-enantiomer是AZD-5991的低活性S型对映体。AZD-5991S-enantiomer是一种Mcl-1抑制剂,FRET实验检测的IC50为6.3μM,SPR实验检测的Kd为0.98μM。
  50. GC33218 CA-5f CA-5f 是一种有效的晚期巨自噬/自噬抑制剂,通过抑制自噬体-溶酶体融合。 CA-5f 增加 LC3B-II(一种监测自噬的标志物)和 SQSTM1 蛋白,并且还增加 ROS 的产生。抗肿瘤活性。
  51. GC33200 Target Protein-binding moiety 13

    PROTAC FKBP12-binding moiety 1

    Target Protein-binding moiety 13 (PROTAC FKBP12-binding moiety 1) 是 FKBP (SLF) 的合成配体。目标蛋白结合部分 13(PROTAC FKBP12 结合部分 1)可用于 PROTAC 的合成。

Items 1701 to 1750 of 2721 total

per page

Set Descending Direction